Is It Time To Think Beyond mRNA For COVID Vaccines? FDA Advisors Intrigued by Novavax As Booster

 
• By Sarah Karlin-Smith
novavax covid prototype vax
Some FDA vaccine advisors suggested looking beyond mRNA vaccines for COVID-19 boosters. • Source: Shutterstock

More from Vaccines

More from Pink Sheet